AEGEAN Phase 3 Trial Results: A New Era in Lung Cancer Therapy
JYOTI The recent recommendation by NICE for AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy marks a significant advancement for…
The recent recommendation by NICE for AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy marks a significant advancement for…